Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
Global vaccine patents rise, as data reveals shift in Big Pharma strategy
Americas
Research reveals an increase in global filings in 2024/2025, but concerns remain over the future of vaccine development in the US.   1 October 2025
Philips wins 'unheard of' trade secret sanctions against Chinese defendants
Americas
The healthtech giant has convinced a US court to freeze the assets of two Chinese startups and their ex-employees for breaching an injunction for trade secret theft of X-ray tubes used in CT scanners.   1 October 2025
Womble Bond Dickinson partners jump to rival firm
Careers
Duo have a combined 60 years of experience in patent litigation, prosecution, and patent portfolio management across mechanical, electrical, medical devices, chemical and pharmaceutical tech.   30 September 2025
Europe
A landmark decision sees the European Patent Office confirm that once all original appeals are withdrawn, third-party interveners cannot continue proceedings.   30 September 2025
Americas
Complaint alleges the pair used Massachusetts company’s patented mRNA TALEN gene-editing technology without permission in multi-billion-dollar cancer therapy deals.   29 September 2025
Americas
Sweeping tariffs send shockwaves through the pharma sector, as experts warn of consumer detriment and supply chain risks.   26 September 2025
Europe
A new survey from LSIPR reveals that European patent practitioners are grappling with client budget constraints and fast-evolving technologies, with most expecting patenting challenges to increase over the next five years.   25 September 2025
Europe
The General Court has handed a win to generic drug makers including Teva and Mylan in the battle over multiple sclerosis drug Tecfidera.   25 September 2025
Careers
The firm’s Technology & Engineering team will be expanded with an expert in patent drafting, prosecution and opposition/defence work across AI, digital health and medical devices.   25 September 2025
Americas
A biotech firm specialising in mRNA therapies alleges AbbVie’s $2.1 billion Capstan purchase was built on stolen lipid nanoparticle trade secrets.   24 September 2025